Skip to main content
Log in

Cardiomyopathy in glycogen-storage disease type III: Clinical and echographic study of 18 patients

  • Original Articles
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Summary

Cardiac examinations were performed on 18 patients with glycogen-storage disease (GSD) type III. Clinical examination was always normal and the electrocardiograms revealed nonspecific data. Similarly, serum muscular enzyme activities were not useful in indicating the presence of cardiomyopathy. Echocardiographic evidence of myocardiopathy was found in five of the 16 children studied (mean age, 9.5 years). Echocardiographic parameters remained stable during the follow-up period (at least 3 years). The other 11 children had no echocardiographic evidence of cardiomyopathy. No relationship was found between peripheral myopathy and cardiomyopathy.

All patients with GSD type III should be regularly investigated by echocardiography in respect of their cardiac muscle status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. De Parscau L, Guibaud P, Labrune P, Odievre M (1988) Evolution à long terme des glycogénoses hépatiques. Etude rétrospective de 76 observations.Arch Fr Pediatr 45:641–645

    PubMed  Google Scholar 

  2. DiMauro S, Miranda AF, Sakoda S, Schon EA, Servidei S, Shanske S, Zeviani M (1986) Metabolic myopathies.Am J Med Genet 25:635–651

    Article  PubMed  Google Scholar 

  3. Hers HG, Van Hoof F (1966) Enzymes of glycogen degradation in biopsy material.Methods Enzymol 8:525–532

    Google Scholar 

  4. Howell RR, Williams JC (1983) The glycogen storage diseases. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown M (ed)The metabolic basis of inherited diseases 1983, McGraw Hill, New York, pp 141–166

    Google Scholar 

  5. Labrune Ph, Chalas J, Pignon JP, Hennion C, Odievre M (1989) La détermination du taux sérique des enzymes musculaires au cours des glycogénoses avec atteinte hépatique: un critère d'orientation diagnostique.Ann Pediatr 36:299–301

    Google Scholar 

  6. Moses SW, Gadoth N, Bashan N, Ben-David E, Slonim A, Wanderman KL (1986) Neuromuscular involvement in glycogen storage disease type III.Acta Paediatr Scand 75:289–296

    PubMed  Google Scholar 

  7. Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV (1984) Cardiac involvement in glycogen storage disease type III: Morphologic and biochemical characterization with endomyocardial biopsy.Am J Cardiol 53:980–981

    Article  PubMed  Google Scholar 

  8. Rossignol AM, Meyer M, Rossignol B, Palcoux MP, Raynaud EJ, Bost M (1979) La myocardiopathie de la glycogénose de type III.Arch Fr Pediatr 36:303–309

    PubMed  Google Scholar 

  9. Servidei S, DiMauro S (1989) Disorders of glycogen metabolism of muscle.Neurol Clin 7:159–178

    PubMed  Google Scholar 

  10. Servidei S, Metlay LA, Chodosh J, DiMauro S (1988) Fatal cardiopathy caused by phosphorylase b kinase deficiency.J Pediatr 113:82–85

    PubMed  Google Scholar 

  11. Servidei S, Riepe RE, Langston C, Tani LY, Bricker JT, Crisp-Lindgren N, Travers H, Armstrong D, DiMauro S (1987) Severe cardiopathy in branching enzyme deficiency.J Pediatr 111:51–56

    PubMed  Google Scholar 

  12. Van Hoof F, Hers G (1967) The subgroups of type III glycogenosis.Eur J Biochem 2:265–270

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Labrune, P., Huguet, P. & Odievre, M. Cardiomyopathy in glycogen-storage disease type III: Clinical and echographic study of 18 patients. Pediatr Cardiol 12, 161–163 (1991). https://doi.org/10.1007/BF02238523

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02238523

Key Words

Navigation